Biogen Idec appoints Spyros Artavanis-Tsakonas chief scientific officer Chris Reidy May 23, 2013 Spyros Artavanis-Tsakonas, HMS professor of cell biology, has been appointed to the post of chief scientific officer of Biogen Idec Inc., the Weston biotechnology company perhaps best known for its multiple sclerosis drugs announced. Read full article
How Buying Primary Care on the Free Market Adds to Doctor Shortages June 24, 2025 Health care policy researcher discusses the pros and cons of concierge medicine
How A Small Number of Mutations Can Fuel Outbreaks of Western Equine Encephalitis Virus April 4, 2025 Study shows how spike protein changes determine the risk of viral outbreaks
2025 Warren Alpert Prize Honors Scientists Whose Discoveries Culminated in Novel HIV Treatment June 19, 2025 Twice-a-year injection with lenacapavir can prevent HIV infection and could speed end of the HIV…